Selling into a wave of new capacity being built by others: management describes its customers' own build-out spending as
The model's full reasoning — Q3 2018 call → NOWe need to determine if management explains the company's current momentum and near-term trajectory chiefly by pointing to a wave of new building, equipping, or capacity-creation being undertaken by other parties, and that this build-out is early or intensifying, with the company already supplying part of what those parties must buy. Let's analyze the transcript. The company is Surmodics, a medical device and diagnostics company. They have various products: drug-coated balloons, catheters, coatings, etc. They have a partnership with Abbott for SurVeil drug-coated balloon. They have their own pipeline. Key points from the call: - Revenue growth driven by royalties, product sales, and license fee from Abbott. - They are investing in R&D for new products. - They mention progress on clinical trials, regulatory clearances. - They talk about their strategic objectives: TRANSCEND trial, R&D pipeline, commercialization strategy. - They mention the Embolitech acquisition for thrombectomy technology. - They discuss their products: Telemark microcatheter, .014 and .018 balloons, etc. - They mention that they are in discussions with potential partners for their products. Now, the question: Does management explain the company's current momentum and near-term trajectory chiefly by pointing to a wave of new building, equipping, or capacity-creation being undertaken by other parties? That is, are customers or end markets building new capacity that the company supplies into? The transcript does not mention any such build-out. There is no mention of customers constructing new facilities, expanding capacity, or any infrastructure build-out. The company's growth is attributed to: - Strong royalty revenue from hydrophilic coatings. - Product sales growth due to customer product launches. - License fee from Abbott. - New product launches like MatrixGuard Diluent. - Progress on clinical trials and regulatory approvals. The company is developing its own products and seeking partners. There is no mention of a wave of capacity creation by others. The only "building" might be the company's own R&D and product development, but that's not others building. Thus, the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| RDCM | RADCOM Ltd. | Q4 2023 | 2024-01-31 | A |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| IPGP | IPG Photonics Corporation | Q3 2021 | 2021-11-02 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
TEL · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by others, that's early or intensif...YES The transcript shows management framing the company's momentum chiefly through a wave of external capacity creation: EV production growth (40% in 2023, expected continued growth next year, with Asia as driver), renewable energy adoption (wind/solar), and AI/cloud applications. They describe others (OEMs, installers 3rd parties) building new productive capability—new EV platforms, renewable sites, AI clusters—while TE already supplies into it via content outperformance and early ramps. Current business is real (sequential order growth, $1.3B pipeline, $100M+ incremental AI revenue). The wave is early/intensifying 2024–2025 (3–4 year programs, more phases ahead, destocking normalizing). This is presented as the primary secular driver offsetting cyclical weakness, not just consumption or pricing. Other elements (destocking, FX) are secondary. Thus all three conditions are met in substance.
ATI · Q1 2018 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by other parties, like customers, t...YES The transcript shows management attributing HPMC momentum chiefly to the "ongoing production ramp of next-generation jet engines at all of our major engine OEM customers" and the "industry is currently in the early phases of a multi-year production expansion." This describes OEMs creating new productive capacity through rate ramps and build growth for next generation engines. Management confirms current business from this wave with "next-generation product sales reached 48% of total jet engine product sales" and "65% increase in next-generation product sales," plus "seventh consecutive quarter of year-over-year margin expansion.
RDCM · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building, equipping, or capacity-creation by other parties (custo...YES The transcript shows management framing 2024 momentum around operators’ ongoing 5G standalone network build-outs (new productive capacity being created by customers), with RADCOM already supplying assurance software to those projects and the wave described as still early and accelerating. All three conditions are met in Eyal Harari’s prepared remarks and Q&A.